AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

INSPIRATION HEALTHCARE GROUP PLC

Board/Management Information Oct 29, 2020

7711_rns_2020-10-29_a93b86be-d675-46f2-82c0-821967c1acfa.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5401D

Inspiration Healthcare Group PLC

29 October 2020

29 October 2020

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Appointment of Non-Executive Director

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company is pleased to announce the appointment of Liz Shanahan to its Board of Directors as a Non-Executive Director with immediate effect.

Liz is a life sciences entrepreneur with extensive experience advising leading global pharmaceutical and healthcare organisations on their communications. She is a Non-Executive Director of UDG Healthcare plc, a company listed on the London Stock Exchange and a constituent of the FTSE 250.

Until 2014, Liz was Global Head of Healthcare & Lifesciences at the NYSE-listed management consultancy, FTI Consulting Inc., who had in 2007 acquired the communications business, Santé Communications, which she founded in 1995. She is a Trustee of CW+, the charitable arm of Chelsea & Westminster Foundation Trust Hospital in London and a member of the organisation's Innovations Advisory Board.

Liz has a degree in Computer Programming & Maths from University College Cork, and is an alumnus of the University of Virginia, Darden School of Business.

Mark Abrahams, Inspiration Healthcare Chairman, said today:

"We are delighted to announce the appointment of Liz to the Board today. She brings extensive experience in the healthcare communications industry coupled with an entrepreneurial spirit so clearly demonstrated by her very successful career and we look forward to working with her as we continue to develop the Group."

The following details in relation to the appointment of Elizabeth Ann Shanahan (aged 56) are disclosed in accordance with Schedule 2(g) of the AIM Rules:

Current Directorships:
SANTE HEALTHCARE CONSULTING LTD
KINGDOM R&D LTD
KINGDOM LABORATORIES LTD
KINGDOM CLINICS LIMITED
KINGDOM THERAPEUTICS LIMITED
CWPLUS LIMITED
UDG HEALTHCARE PLC
AKUSUS HOLDINGS LIMITED
ONETOUCHTELECARE LTD
Previous Directorships:
CONNECTED TECH GROUP LTD
CHELSEA & WESTMINSTER FOUNDATION TRUST

Elizabeth Shanahan does not hold any ordinary shares in the Company. There is no further information to be disclosed in relation to Elizabeth Shanahan's appointment pursuant to Schedule 2 paragraph (g) of the AIM Rules.

Enquiries:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer
Tel: 01455 840555
Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie
Tel: 0207 397 8900
Cadogan PR                                                                                         

Alex Walters

[email protected]
Tel: 07771 713608

About Inspiration Healthcare 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping  resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products.  The Group generates approximately 60% of its revenues from export markets and around two-thirds of its revenues come from its own-branded products. 

With product availability actively promoted to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspiration-healthcare.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAVVLFLBBLXFBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.